SNG-8006

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSNG-8006
Drug Alias Nameestrogen receptor alpha-36 antagonist (Shenogen Pharma)SNG-8006
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha degraders
TargetsEstrogen receptor alpha
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenogen Pharma Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenogen Pharma Group Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A